Equities not available in your region
CRNX icon

Crinetics Pharmaceuticals (CRNX)

NASDAQ

83,47 $

41,46 $ (

+98,67 %

)

1D
5D
1M
6M
1Y
5Y
Market open

CRNX: 83,47 $ / ₿ 0.0013 BTC / 131083 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

42,02 $
25,83 $ - 57,99 $
8,80 mia. $
12.15
83,58 $
71.995.512,28 $
105,44 mio.
83,47 $ - 83,48 $
83,47 $ - 83,59 $
Yes

What is Crinetics Pharmaceuticals (CRNX)?

Crinetics Pharmaceuticals Inc er en farmaceutisk virksomhed i kommerciel fase med fokus på opdagelse, udvikling og kommercialisering af nye terapeutika til sjældne endokrine sygdomme og endokrinrelaterede tumorer. Dets hovedprodukt, Palsonify (paltusotine), er en oral behandling, der tages én gang dagligt og er godkendt af FDA til voksne med akromegali, som har haft en utilstrækkelig respons på kirurgi og/eller for hvem kirurgi ikke er en mulighed. Derudover omfatter virksomhedens udviklingspipeline adskillige programmer, herunder en undersøgelseskandidat i sen fase, atumelnant, der i øjeblikket er under udvikling til CAH og ADCS, og CRN09682, en NDC-kandidat, der udvikles til behandling af SST2-udtrykkende NETs og andre SST2-udtrykkende solide tumorer.

The Crinetics Pharmaceuticals (CRNX) stock price has been rising

The Crinetics Pharmaceuticals, Inc. Common Stock (CRNX) stock price today is 83,47 $, reflecting a +98,67 % move since the market opened. The company’s market capitalization stands at 8,80 mia. $, with a daily trading volume of 72,00 mio. $ shares. For investors tracking price trends, Crinetics Pharmaceuticals, Inc. Common Stock stock has ranged between 83,47 $ and 83,59 $ today. The previous closing price was 42,02 $.

Get started with Crinetics Pharmaceuticals (CRNX)

Ready to get started? Follow the steps below, or read our guide on how to buy Crinetics Pharmaceuticals stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy CRNX

Search for CRNX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy CRNX.

CRNX FAQs

CRNX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

CRNX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Crinetics Pharmaceuticals, Inc. Common Stock (CRNX) has traded between a low of 25,83 $ and a high of 57,99 $.

CRNX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Crinetics Pharmaceuticals? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
CRNX icon
CRNX

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

AFMDQ icon

AFMDQ

NCRA icon

NCRA

PFSA icon

PFSA

BGXXQ icon

BGXXQ

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

FATPQ icon

FATPQ

CPTWF icon
KUKEY icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.